ACVBP-R regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Adriamycin-Cytoxan-Vindesine-Bleomycin-Prednisone-Rituximab Regimen
Overview
ACVBP-R regimen refers to a chemotherapy regimen consisting of doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone, and rituximab used in the treatment of non-Hodgkin lymphoma.
Regimen
ADoxorubicin (Adriamycin)
CCyclophosphamide
VVindesine
BBleomycin
PPrednisone
RRituximab
Indications
References
- ↑ Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O; et al. (2011). “Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial”. Lancet. 378 (9806): 1858–67. doi:10.1016/S0140-6736(11)61040-4. PMID 22118442.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH